Table 4.
Variable | Change during Week 1 | Change during Week 2 | Change during Week 3 | Change during Week 4 | |
---|---|---|---|---|---|
Total TCM symptom score | A | −0.01±0.03 | −0.07±0.05 | −0.15±0.10 | −0.22±0.10 |
B | −0.06±0.042) | −0.15±0.062) | −0.27±0.121) | −0.37±0.141) | |
C | −0.1±0.074) | −0.2±0.143) | −0.33±0.174) | −0.44±0.214) | |
Major symptoms | A | −0.02±0.03 | −0.08±0.06 | −0.17±0.11 | −0.24±0.12 |
B | −0.06±0.031) | −0.17±0.041) | −0.29±0.11 | −0.40±0.14 | |
C | −0.11±0.083) | −0.21±0.16 | −0.35±0.22 | −0.47±0.28 | |
Secondary symptoms | A | 0.00±0.02 | −0.06±0.04 | −0.12±0.08 | −0.19±0.07 |
B | −0.05±0.05 | −0.13±0.09 | −0.24±0.14 | −0.33±0.15 | |
C | −0.08±0.06 | −0.18±0.12 | −0.31±0.09# | −0.39±0.084) |
KRG, Korean Red Ginseng; TCM, traditional Chinese medicine.
Data are expressed as mean ± standard deviation.
A: participants were given placebo 3.6 g/d;.B: participants were given KRG 1.8 g/d; C: participants were given KRG 3.6 g/d.
For the difference between the changes during KRG 1.8 g versus placebo, using an effect model; P < 0.05 compared with the control.
For the difference between the changes during KRG 1.8 g versus placebo, using an effect model; P < 0.01 compared with the control.
For the difference between the changes during KRG 3.6 g versus placebo, using an effect model; P < 0.05 compared with the control.
For the difference between the changes during KRG 3.6 g versus placebo, using an effect model; P < 0.01 compared with the control.